Share
A drug used to treat type 2 diabetes could offer a simple and cheap solution to reduce dangerous side effects of steroid treatment, new research from Queen Mary University of London suggests. The phase 2 clinical trial, funded by Barts Charity, looked at the effects of the diabetes drug metformin on patients currently receiving high...
Share
The results of a recent study show that One Drop’s AI-powered glucose predictions are 91.9% accurate for hypoglycemia and 91.6% accurate for hyperglycemia The digital therapeutics company One Drop today presented new results for continuous glucose monitor-based glucose predictions at The 13th International Conference on Advanced Technologies & Treatments for Diabetes in Madrid, Spain....
Share
Studies linking statins to diabetes receive media attention but should not distract clinicians from the goal of reducing cardiovascular risk. Almost eight years after the Food and Drug Administration (FDA) added a warning to statin labels about the drugs increasing fasting blood sugar and hemoglobin A1C levels — and by inference raising the risk of...
Share
Finding your first job can be a challenge for early-career clinicians. Luckily, Endocrine News talked to some seasoned pros with advice on how to find a setting that appeals to you, your family, and your professional goals. What’s the best way to find a clinical position as an early-career endocrinologist? Flexibility, focus, and knowing what...
Share
Study finds eating more at breakfast instead of dinner could prevent obesity Eating a big breakfast rather than a large dinner may prevent obesity and high blood sugar, according to new research published in The Journal of Clinical Endocrinology & Metabolism. “Our results show that a meal eaten for breakfast, regardless of the amount of calories...
Share
New recommendations include romosozumab therapy for high risk patients The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture. The U.S. Food and Drug Administration approved romosozumab in April 2019,...
Share
A novel way to reach even more patients, clinicians, and researchers is to take your endocrinology skill into the business world. Here we highlight an ENDO 2020 session that will show attendees how industry could be a viable route for researchers and physicians alike. Last year, at ENDO 2019 in New Orleans, three entrepreneurs at...
Share
While the health risks linking tobacco use by pregnant woman has been long understood, vaping presents a new frontier. A recent mouse study from the Journal of the Endocrine Society appears to show that there are some definite ill effects of e-cigarettes and the health of the offspring. We’ve known for decades about the health...
